Quest Partners LLC Sells 7,058 Shares of Encompass Health Co. (NYSE:EHC)

Quest Partners LLC reduced its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 43.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,067 shares of the company's stock after selling 7,058 shares during the quarter. Quest Partners LLC's holdings in Encompass Health were worth $876,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of EHC. Harbor Capital Advisors Inc. raised its position in Encompass Health by 275.7% in the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company's stock valued at $3,071,000 after purchasing an additional 26,270 shares during the last quarter. QRG Capital Management Inc. raised its position in Encompass Health by 85.6% in the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company's stock valued at $1,232,000 after purchasing an additional 6,627 shares during the last quarter. SG Americas Securities LLC bought a new position in Encompass Health in the second quarter valued at about $2,204,000. Los Angeles Capital Management LLC raised its position in Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company's stock valued at $4,860,000 after purchasing an additional 42,338 shares during the last quarter. Finally, Kennedy Capital Management LLC raised its position in Encompass Health by 19.6% in the first quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company's stock valued at $8,235,000 after purchasing an additional 16,318 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on EHC shares. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Stephens restated an "overweight" rating and set a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. UBS Group raised their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Wednesday, September 25th. Barclays raised their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Finally, Truist Financial reaffirmed a "buy" rating and set a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Encompass Health presently has an average rating of "Buy" and a consensus target price of $107.11.

Encompass Health Stock Down 0.2 %

Shares of NYSE:EHC opened at $98.90 on Thursday. The stock has a market cap of $9.96 billion, a price-to-earnings ratio of 23.89, a PEG ratio of 1.31 and a beta of 0.88. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12-month low of $63.78 and a 12-month high of $104.55. The business's 50 day moving average is $96.83 and its 200 day moving average is $90.63.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. Encompass Health's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 earnings per share. On average, sell-side analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health's dividend payout ratio (DPR) is currently 16.43%.

Encompass Health announced that its Board of Directors has approved a share buyback program on Wednesday, July 24th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to repurchase up to 5.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's management believes its stock is undervalued.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.